Shares of Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) traded up 1.4% during trading on Tuesday . The company traded as high as $4.64 and last traded at $4.29. 44,171 shares traded hands during trading, a decline of 74% from the average session volume of 166,781 shares. The stock had previously closed at $4.23.
Analysts Set New Price Targets
AMIX has been the subject of several recent research reports. Zacks Research raised Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings downgraded shares of Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $42.00.
Get Our Latest Analysis on Autonomix Medical
Autonomix Medical Trading Down 6.5%
About Autonomix Medical
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Further Reading
- Five stocks we like better than Autonomix Medical
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
